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Summary statement An inducible mouse was developed to show that CIZ1 extends the 
window of cardiomyocyte proliferation and reduces the impact of injury on cardiac function 
 
Abstract Myocardial injury in mammals leads to heart failure through pathological cardiac 
remodelling that includes hypertrophy, fibrosis and ventricular dilatation. Central to this is 
inability of the mammalian cardiomyocyte to self-renew due to entering a quiescent state 
after birth. Modulation of the cardiomyocyte cell-cycle after injury is therefore a target 
mechanism to limit damage and potentiate repair and regeneration. Here we show that 
cardiomyocyte specific over-expression of the nuclear-matrix associated DNA replication 
protein, CIZ1, extends their window of proliferation during cardiac development, delaying 
onset of terminal differentiation without compromising function. CIZ1 expressing hearts are 
enlarged, but the cardiomyocytes are smaller with an overall increase in number, correlating 
with increased DNA replication after birth and retention of an increased proportion of mono-
nucleated cardiomyocytes into adulthood. Furthermore, these CIZ1 induced changes in the 
heart reduce the impact of myocardial injury, identifying CIZ1 as a putative therapeutic target 
for cardiac repair 
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 Introduction Heart disease is a leading cause of death in the developed world, with major 
efforts aimed towards repairing the heart after injury. A key issue that compromises cardiac 
repair is resistance to regeneration of differentiated mammalian myocardium. Thus, any 
significant insult that induces cardiomyocyte (CM) death results in irreparable damage. This 
is exacerbated by remodelling events that drive cardiac fibrosis, development of 
arrhythmias, and heart failure. Increasing effort has been directed towards understanding 
molecular processes that underlie CM development, to unlock ‘hidden’ regeneration 
potential. Greater understanding of mechanisms that control renewal could facilitate 
translation into therapeutic application. Central to this is the resistance of the adult CM to re-
enter the cell cycle following terminal differentiation (Pasumarthi and Field, 2002). In humans 
the majority of CM are mono-nucleated, some bi-nucleated and a very small proportion 
multi-nucleated (Olivetti et al., 1996). In contrast, mouse CMs undergo nuclear division 
without cytokinesis shortly after birth, so the majority become suspended in a bi-nucleated 
state in the adult heart. Stresses such as hypoxia induce tissue remodelling through CM 
mediated activation of resident non-myocytes (NM) resulting in deposition of extracellular 
matrix and formation of scar tissue that lacks key properties of healthy myocardium (Turner, 
2011; Frentzou et al., 2015). Strategies for regenerating damaged myocardium include stem 
cell therapies, including bone marrow, embryonic and induced pluripotent stem cells 
(reviewed in (Ainscough et al., 2012). Methods have also been reported for direct 
reprogramming of cardiac fibroblasts into immature CM (Ieda et al., 2010; Qian et al., 2013). 
However, these approaches are not yet sufficiently advanced to enable correct integration of 
appropriately differentiated cells into local resident myocardium, with clinical trials showing 
limited improvement (Behfar et al., 2014; Broughton and Sussman, 2016). The potential for 
resident CM to re-enter cell cycle and proliferate to repair damage is an attractive prospect. 
Unlike mammals, lower vertebrates are able to achieve this, involving an initial phase of de-
differentiation around the damaged zone, and subsequent proliferation of nearby healthy CM 
(Jopling et al., 2010). The neonatal mouse heart retains similar repair capacity, but this is 
lost as the cells bi-nucleate within the first weeks after birth (Porrello et al., 2011). Indeed, bi-
nucleated cells in adult myocardium are terminally quiescent, whereas the small proportion 
of mono-nucleated cells retain proliferation potential (Bersell et al., 2009). Thus, a viable 
alternative approach to stem cell therapy might be manipulation of regulatory mechanisms to 
shift the CM population towards the mono-nucleated form. In mammalian cells G1 
progression is regulated by cyclin D/CDK4/6 and cyclin E/CDK2 (Sherr and Roberts, 2004), 
while S-phase entry is promoted by cyclin E/CDK2 and cyclin A/CDK2 (Coverley et al., 
2002). The nuclear matrix protein CDKN1A-interacting zinc finger protein-1 (CIZ1) plays a 
pivotal role in co-ordinating activity of these molecules to promote initiation of DNA 
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replication, by targeting them to specific sub-nuclear sites (Coverley et al., 2005; Ainscough 
et al., 2007; Copeland et al., 2010; Copeland et al., 2015). Here, we use a new conditional 
transgenic mouse model to demonstrate that CIZ1 can promote CM proliferation and 
enhance formation of mono-nuclear cells, without compromising cardiac function. The data 
also suggest that CIZ1 is a candidate therapeutic target for reducing the impact of injury on 
myocardial function. 
 
Results 
 
Differential expression of CIZ1 in CM and NM populations of the heart Purified CM were 
isolated from mouse hearts by a modified langendorff perfusion method (Frentzou et al., 
2015). Purity was confirmed by lack of expression of the NM marker Col1a1 (Fig 1A). 
Although some CM were also present in the NM fraction, detected by expression of aMHC 
(Fig 1B), qRT-PCR showed that ~90% of Ciz1 mRNA in the heart was NM derived, 
comprising fibroblast, endothelial, smooth muscle and inflammatory cells (Fig 1C). All of 
these cell types retain ‘proliferation potential’, unlike the terminally differentiated CM 
population in which CIZ1 expression was approximately 20-fold less. However, at the protein 
level CIZ1 foci were readily observed in CM nuclei, suggesting long-term retention of ‘old’ 
CIZ1 in this cell type after differentiation, with no further role in promoting replication initiation 
(Fig 1D). 
 
Conditional CIZ1 mouse model To test whether renewed production of CIZ1 in CM could 
prolong cell cycle activity we produced a novel transgenic mouse in which expression of new 
CIZ1 protein could be induced. The model utilized two transgenes, one encoding 
transactivator and the other encoding a responsive LacZ/GFP-CIZ1 reporter (Fig 1E). CM 
specific transactivator expression was achieved through the aMHC promoter, which drives 
expression in atrial CM during embryogenesis, and is activated in ventricular CM at birth and 
throughout adulthood. The CM specific transactivator molecule drives LacZ/GFP-Ciz1 
expression by binding the tetracycline response element (TRE). We previously employed the 
same transactivator line to drive specific expression of LacZ/AT1R in cardiomyocytes, and 
reported clear cell type specificity through extensive analysis of LacZ reporter expression in 
a range of tissues and developmental stages (Ainscough et al., 2009). Thus, LacZ and GFP-
CIZ1 were only expressed in CM of double transgenic mice (Tg). From three transgenic 
founders we selected two lines for further characterization (see methods). Line CIZ24 
expressed CM specific CIZ1 at approximately 100-fold higher than endogenous levels 
(Fig1F), comparable to the level seen in adult testis (Greaves et al., 2012). Thus, although 
this level of CIZ1 exceeds that in most other tissues and developmental stages, it remains 
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within physiologically relevant levels. As with endogenous CIZ1, GFP-CIZ1 protein 
accumulated in CM nuclei (Fig1G). This new model provided a unique opportunity to 
address the influence of enhanced CIZ1 on cell cycle progression specifically in CM, and to 
assess its impact on cardiac function. 
 
CIZ1 expressing hearts are enlarged but not functionally impaired CIZ24 mice were 
examined for evidence of cardiac disorder at 1, 3, 10, and 16-weeks after birth (Fig 2A). 
Neonatal Tg hearts were not significantly larger, but enlargement became evident and 
sustained at later stages in both males and females. Millar catheter assessment at 16-weeks 
found no evidence that the hearts were functionally compromised, with no significant 
differences in end systolic or diastolic volumes, ejection fraction or stroke volume (Fig 2B, 
Table 1). Importantly this showed that continued production of CIZ1 in mature CM is not 
detrimental to heart function. Consistent with this, histological assessment demonstrated 
that enlargement was not associated with cellular hypertrophy, fibrosis or dilatation. Instead 
Tg CM were significantly smaller in cross section (Fig 2 C,D), indicating that the total CM 
number in the adult heart was greater than that in control hearts. 
 
CIZ1 expressing hearts have more mono-nucleated CM CM were isolated from hearts at 
12-weeks and individual nuclei counted (Fig 3A). The proportion of bi-nucleated CM was 
significantly reduced in Tg hearts (69.5% from 88%), whereas the mono-nucleated 
population was significantly increased (20.15% from 6.5%). A small increase in number of 
multi-nucleated CM was also noted. It was difficult to assign some cells into distinct groups 
as the nuclei were partially divided (Fig 3B). Together, the results (smaller cells, larger heart, 
increase in mono-nuclear CM) suggest increased cell cycle activity and proliferation after 
birth. 
 
An extended window for CM self-renewal Using stringent criteria for positive identification 
of CM in tissue sections (Frentzou et al., 2015), in vivo EdU incorporation at 3-weeks 
showed that the number of replicating CM nuclei was small in both WT and Tg hearts. To 
determine when cell cycle activity declines, 2–week old animals were subjected to EdU 
incorporation for 48-hours. The number of CM undergoing DNA synthesis was significantly 
higher in Tg hearts, while the proportion of replicating NM was reduced (Fig 3C,D). This 
correlated with a sustained increase in proportion of CM in Tg hearts (Fig 3E). Thus, the 
window of CM proliferation is extended in CIZ1 expressing hearts. 
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 CIZ1 reduces the impact of injury on cardiac function 16-week old mice were subjected 
to coronary artery ligation and left ventricular pressure-volume measurements compared to 
unligated controls after 4-weeks (Fig 4A, Table 1). Although cardiac function was adversely 
affected in both groups, Tg animals were less affected, exhibiting 36% reduction in ejection 
fraction (67%-43%) compared to 54% reduction (63%-34%) in the WT animals. This 
correlated with increased end systolic and diastolic volumes indicative of cardiac dilatation, 
most exaggerated in WT hearts (Table 1). Representative hearts sectioned across the 
ligature showed no notable differences with both WT and Tg hearts exhibiting localised 
fibrosis with NM infiltration (Fig 4B). 48-hours prior to culling, three mice from each group 
were injected with EdU to enable assessment of DNA replication. Although the ratio of 
CM:NM in healthy myocardium appeared similar between groups, the overall replication 
index was slightly higher in Tg animals (Fig 4C,D), albeit confined to cell nuclei with 
characteristic NM appearance. Thus, we observed no direct evidence for generation of new 
CM in Tg hearts after injury, suggesting that the lessened impact of injury might be directly 
related to the increased number of smaller mono-nucleated CM in the Tg heart.  
 
Discussion 
Together the data demonstrate that CIZ1 can modulate cell cycle activity after birth and 
reduce the impact of injury to the heart. This is consistent with previous evidence that 
suggested a role for CIZ1 in DNA replication (Coverley et al., 2005), via interaction with cell 
cycle regulators (Mitsui et al., 1999; den Hollander and Kumar, 2006; Copeland et al., 2010; 
Copeland et al., 2015). Our findings indicate that CIZ1 could be an important target for 
assisted regeneration, provided potential benefits outweigh possible risks. Although a range 
of alternatively spliced isoforms are expressed during embryonic development, adult tissues 
primarily express full length Ciz1 (Greaves et al., 2012). Some variants have been 
associated with a range of proliferative disorders including cancers, suggesting that 
deregulation of normal CIZ1 function might negatively impact on identity (Warder and 
Keherly, 2003; den Hollander et al., 2006; Rahman et al., 2007; Higgins et al., 2012). 
However, complete lack of CIZ1 has also been shown to promote tumorigenesis (Nishibe et 
al., 2013), suggesting tumour suppressor properties. Although there is no direct evidence to 
implicate full-length CIZ1 in any disease state the available evidence does suggest that 
caution is warranted. Given that expression of CIZ1 is tightly regulated during development 
(Greaves et al., 2012), and deviation from normal has potential to promote tumorigenesis, 
care must be taken in any attempt to manipulate CIZ1 for therapeutic gain. 
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A number of investigations have previously reported reactivation of the CM cell cycle 
through direct manipulation of other regulators. These include cyclins D1-3 (Soonpaa and 
Field, 1997; Soonpaa et al., 1997; Pasumarthi and Field, 2002; Zhu et al., 2009), cyclin A2 
(Chaudhry et al., 2004; Cheng et al., 2007) CDK2 (Liao et al., 2001), p27 KIP1 (Poolman et 
al., 1999), p53 and p193 (Nakajima et al., 2004). Up-regulation of cyclin D1 promoted multi-
nucleation, while CDK2 shifted the balance towards mono-nucleation (Soonpaa et al., 1997; 
Liao et al., 2001). Promisingly, cyclins A2 and D2 were reported to promote infarct 
regression (Pasumarthi et al., 2005; Cheng et al., 2007). Less promising, heart enlargement 
induced by CDK2 over-expression did not persist into adulthood, and the cell cycle 
modulating effect of p27 deletion was lost after 6-days (Poolman et al., 1999). For CIZ1 we 
found that the influence was comparatively stable, with mice exhibiting enlarged hearts even 
at 20-weeks. This might reflect the central role of CIZ1 in the DNA replication process, acting 
as a hub to bring together each of it’s interacting partners in a timely manner (Ainscough et 
al., 2007; Copeland et al., 2010). However, lack of direct evidence for continued DNA 
replication at later time points means this possibility requires further investigation. 
In association with the increased number of small CM a significant shift was observed in the 
balance from bi-nucleation towards mono-nucleation. This finding is important, as it was 
demonstrated previously that, in species which have myocardial regenerative potential, 
mono-nucleated CM divide more successfully than bi-nucleated CM (Matz et al., 1998). Over 
90% of zebrafish CM, which have a high regenerative capacity, are mono-nucleated (Wills et 
al., 2008). It has also been shown that differentiated mouse mono-nucleated CM have 
regenerative potential, with capacity to disassemble their sarcomeres and undergo cell 
division (Bersell et al., 2009). It is not clear, therefore, why the mononucleated CM in the 
human heart (majority population) are resistant to regeneration, suggesting additional as yet 
unexplained blocks to cell cycle reactivation are yet to be discovered. Interestingly, knockout 
of the homebox gene Meis1 in mice promoted mono-nucleation (Mahmoud et al., 2013), 
suggesting that MEIS1 is one component that acts to restrain cell cycle re-entry. Our results 
show that CIZ1 promotes generation of mono-nucleated CM and reduces the impact of 
injury on cardiac function in the adult. However, in isolation modulation of CIZ1 is not likely 
to be sufficient to induce cardiac regeneration and repair after injury. Further work to unlock 
the mechanisms that regulate cell cycle inhibition in ageing cardiomyocytes may enable 
CIZ1 modulation to be a useful component of a toolbox for regenerative medicine. 
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 Materials and Methods 
 
Animals All experiments were performed with ethical approval from the University of Leeds 
under UK Home Office authorization. GFPCiz1/LacZ-Tg mice were generated by pronuclear 
injection of an inducible GFP-full length mouse Ciz1 construct into CBA/C57BL6 fertilized 
eggs as described previously (Ainscough et al., 2009). Three positive lines were identified 
(CIZ12,15, 24) and copy number and integrity assessed by Southern blot. Each line was 
crossed with αMHC-tTA mice (FVB.Cg-Tg(Myh6-tTA)6Smbf/J; Jackson laboratories) to drive 
CM specific expression. CIZ15/tTA mice did not express Ciz1 or LacZ. CIZ12/tTA showed 
low-level Ciz1 and mosaic LacZ, while CIZ24/tTA showed robust Ciz1 expression and LacZ 
in all CM. αMHC-tTA was detected using primer tTA1 (5’-CGCTGGGGGGCATTTTACTTTA-
3’) with tTA2 (5’-CATGTCCAGATCGAAATCGTC-3’); GFPCiz1/LacZ using primer LacZ4 (5’-
AATGGTCTGCTGCTGCTGAACG-3’) with LacZ5 (5’-GGCTTCATCCACCACATACAGG-3’). 
 
Cardiac function and myocardial injury MI was induced by left coronary artery ligation at 
the atrial inferior border. Millar catheter analysis was performed 4-weeks later as described 
previously (Ainscough et al., 2009; Frentzou et al., 2015). A 1.4F miniature pressure-volume 
catheter (SPR-839, Millar Instruments) was inserted through the right carotid and ascending 
aorta into the left ventricle. Data was recorded using MPVS-300 (Millar Instruments), 
Chart5Pro (AD instruments) and PVAN 3.6. 
 
Cardiac weight index Excised hearts were washed in PBS, atria removed for LacZ 
assessment, and ventricles blotted and weighed. Samples not used immediately for RNA or 
histology were snap-frozen and stored at -80oC. Ventricle/body weight (mg/g) was recorded 
as cardiac weight index. 
 
Cardiac cell isolation and qRT-PCR CM and NM were separated into fractions using a 
modified Langendorff-apparatus as described (Frentzou et al., 2015). Following filtration to 
remove clumps a CM pellet was settled by gravity, then washed in cold digestion buffer. For 
RNA, CM were purified away from remaining NM by resuspension and centrifugation in cold 
PBS (3x1min) at 500rpm, then resuspended in TRI-reagent (Ambion). The NM supernatant 
from the CM settling was further cleared by sequential centrifugation (4x1min). The 
remaining supernatant was centrifuged at 1500rpm (10min). The resultant NM pellet was 
resuspended in TRI-reagent. Extracted RNAs were DNase treated, then reversed 
transcribed with Superscript III (Invitrogen). qRT-PCR was performed using gene specific 
primer-probes for Ciz1, Col1α1, αMHC and Gapdh (Table 2), on an ABI-7500-PCR system, 
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normalised to Gapdh. Relative expression was calculated as 2-ΔCTx100 and presented as % 
Gapdh. 
 
DNA replication/EdU assay Mice were injected once daily with 100µg EdU in PBS, and 
hearts excised after 24-48 hours. Click-iT EdU assay was carried out on 10μm heart 
cryosections following manufacturers instructions (MolecularProbes). 
 
Immunofluorescence Isolated CMs were fixed in cold ethanol. Endogenous CIZ1 was 
detected using antibody-1793 (Coverley et al., 2005). Cell membranes and nuclei were 
visualised with wheat germ agglutinin (Vector laboratories) and Hoechst 33258 (Sigma), 
respectively. Samples were mounted in VectorShield (Vector laboratories). Images were 
taken using a Zeiss AxioImager Z.1 microscope and AxioVision software (Zeiss), then 
prepared using Adobe Photoshop. 
 
Statistical analysis  Data are expressed as mean ±SEM, analysed by two-tailed t-test using 
GraphPad Prism5. (*p≤0.05, **p≤0.01,***p≤0.001) 
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Figures 
 
 
 
 
Figure 1 
A Determination of cardiomyocyte (CM) fraction purity by qRT-PCR. Col1a1 was expressed 
exclusively in non-myocytes (NM). B αMHC was primarily restricted to CM. αMHC in NM 
suggests presence of CM co-sedimenting with NM. C Ciz1 was expressed primarily in NM. D 
CIZ1 protein is localised to nuclear speckles in adult WT CM, detected with antibody 1793. 
Scale bar=10um. E Schematic representation of activator and responder transgenes, with 
PCR assay for positive identification. Tg mice were positive for both transgenes. F Relative 
Ciz1 expression in isolated CM of WT and Tg mice. G Nuclear localisation of ectopic CIZ1 
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was demonstrated by GFP fluorescence (green) in fresh sections of 3-week old Tg hearts, 
confirmed by LacZ staining (blue). Scale bar=100um. n=3-4 mice/group. 
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 Figure 2 
A Cardiac weight index of WT (white) and Tg (green) males and females from neonate to 
young adulthood. (n=8-17 mice/group). B Millar catheter assessment of cardiac function at 
16-weeks showed no difference between groups. C Ventricular CM cross sectional area and 
number/field, determined using the membrane stain WGA and calculated using ImageJ 
(n=7-10 images/mouse, 3 mice/group). D Differential cross sectional area was maintained at 
10-16 weeks. Scale bar=50um. 
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 Figure 3  
A Proportion of mono-, bi-, tri- and tetra-nucleated CM in WT (white) and Tg (green) hearts 
at 12-weeks (n= >500 CM/mouse, 4 mice/group), with representative examples of GFP 
positive (green) Tg nuclei. B Examples of partially divided GFP positive nuclei (arrows). C 
Hearts of 2-week old Tg mice had 3-fold more replicating CM than WT, detected following 
incorporation of EdU for 48-hours. (n=10-12 sections/mouse, >1000 nuclei, 3 mice/group). A 
slight decrease was observed in replicating NM. D Examples of replicating Tg NM (short 
arrow) and CM (long arrow). Cell identity was based on nuclear size/position relative to WGA 
stained membrane (Frentzou et al., 2015). E CM:NM ratio during development from neonate 
to young adulthood, in WT (white) and Tg (green) mice. Scale bar=20um. 
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Figure 4 
A 16-week old WT and Tg mice were subjected to coronary artery ligation. At 20-weeks 
ejection fraction was significantly better in Tg mice. B Representative haematoxylin and 
eosin stained sections of ligated hearts at 20-weeks. Magnified images show border zone 
between healthy (pink) and damaged myocardium, which appears blue due to increased NM 
density. Scale bar=200µm. 
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C Hearts of ligated Tg mice at 20-weeks exhibited marginally increased replication index, 
while CM:NM ratio was not different (n=613-940 nuclei, 7-10 images/mouse, 3 mice/group). 
D Representative images of EdU positive nuclei (red) in WT and Tg hearts. Nuclei-blue; cell 
membrane-green. Scale bar=20um. 
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Table 1. Assessment of cardiac function 
Cardiac 
parameter 
WT 
(n=8) 
Tg 
(n=8) 
WT-MI 
(n=4) 
Tg-MI 
(n=7) 
Blood Pressure 
(mmHg) 
84.13 ± 2.4 81.3 ± 3.6  75.00 ± 7.07 79.00 ± 4.87 
Heart Rate 
(beats/min) 
551.5 ± 21.4 520 ± 21  554.5 ± 24.73  497.7 ± 20.91 
End Systolic 
Volume (µl) 
9.4 ± 1.5 9.1 ± 2.0  25.76 ± 1.96 22.58 ± 2.51 
End Diastolic 
Volume (µl) 
19.7 ± 1.2 21.3 ± 2.9  31.31 ± 2.53  34.49 ± 3.43 
End Systolic 
Pressure (mmHg) 
92.8 ± 4.7 84.4± 3.7  109.4 ± 5.07  94.03 ± 4.60 
End Diastolic 
Pressure (mmHg) 
8.0 ± 1.7 7.0 ± 0.8  13.11 ± 4.15  15.05 ± 0.65 
Stroke Volume 
(µl) 
13.8 ± 1.4 14.5 ± 1.4  12.42 ± 1.34  15.18 ± 1.20 
Ejection Fraction 
(%) 
63.0 ± 4.89 67.1 ± 5.40  34.10 ± 1.94 43.20 ± 1.72 
Cardiac output 
(µl/min) 
7450 ± 541.1 7372 ± 710.9 6802 ± 525.7  7585 ± 726.5 
dP/dtmax 11080 ± 936 10130 ± 860  8524 ± 783.5  7817 ± 315.8 
     
 
Hemodynamic assessment of Tg and WT mice by Millar catheter with and 
without coronary artery ligation for 4-weeks.  
B
io
lo
gy
 O
pe
n 
• 
A
dv
an
ce
 a
rt
ic
le
Table 2. Primer-probe sets for quantitative RT-PCR 
Gene ID Position Product size 
 
Ciz1 
 
Mm00503766_m1 
 
Exon 11-12 
 
77 bp 
Col1a1 Mm01302043_g1 Exon 31-32 117 bp 
aMHC Mm00440354_m1 Exon 15-16 70 bp 
GapdH Mm99999915_g1 Exon 2-3 107 bp 
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